1. Carmeliet, P.; Jain, R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473, 298–307. [CrossRef]
2. Folberg, R.; Maniotis, A.J. Vasculogenic mimicry. APMIS 2004, 112, 508–525. [CrossRef]
3. Hendrix, M.J.; Seftor, E.A.; Seftor, R.E.; Chao, J.T.; Chien, D.S.; Chu, Y.W. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma. Pharmacol. Ther. 2016, 159, 83–92. [CrossRef]
4. Maniotis, A.J.; Folberg, R.; Hess, A.; Seftor, E.A.; Gardner, L.M.; Pe'er, J.; Trent, J.M.; Meltzer, P.S.; Hendrix, M.J. Vascular channel formation by human melanoma cells in vivo and in vitro: Vasculogenic mimicry. Am. J. Pathol. 1999, 155, 739–752. [CrossRef]
5. Leslie, M. Tumors’ do-it-yourself blood vessels. Science 2016, 352, 1381–1383. [CrossRef]
6. Chelazzi, C.; Villa, G.; Mancinelli, P.; De Gaudio, A.R.; Adembri, C. Glycocalyx and sepsis-induced alterations in vascular permeability. Crit. Care 2015, 19, 26. [CrossRef]
7. Tarbell, J.M.; Cancel, L.M. The glycocalyx and its significance in human medicine. J. Intern. Med. 2016, 280, 97–113. [CrossRef]
8. Kang, H.; Wu, Q.; Sun, A.; Liu, X.; Fan, Y.; Deng, X. Cancer Cell Glycocalyx and Its Significance in Cancer Progression. Int. J. Mol. Sci. 2018, 19, 2484. [CrossRef]
9. Paszek, M.J.; DuFort, C.C.; Rossier, O.; Bainer, R.; Mouw, J.K.; Godula, K.; Hudak, J.E.; Lakins, J.N.; Wijekoon, A.C.; Cassereau, L.; et al. The cancer glycocalyx mechanically primes integrin-mediated growth and survival. Nature 2014, 511, 319–325. [CrossRef]
10. Barnes, J.M.; Kaushik, S.; Bainer, R.O.; Sa, J.K.; Woods, E.C.; Kai, F.; Przybyla, L.; Lee, M.; Lee, H.W.; Tung, J.C.; et al. Tension-mediated glycocalyx-integrin feedback loop promotes mesenchymal-like glioblastoma. Nat. Cell Biol. 2018, 20, 1203–1214. [CrossRef]
11. Qazi, H.; Palomino, R.; Shi, Z.D.; Munn, L.L.; Tarbell, J.M. Cancer cell glycocalyx mediates mechanotransduction and flow-regulated invasion. Integr. Biol. (Camb) 2013, 5, 1334–1343. [CrossRef]
12. Okada, H.; Takemura, G.; Suzuki, K.; Oda, K.; Takada, C.; Hotta, Y.; Miyazaki, N.; Tsujimoto, A.; Muraki, I.; Ando, Y.; et al. Three-dimensional ultrastructure of capillary endothelial glycocalyx under normal and experimental endotoxemic conditions. Crit. Care 2017, 21, 261. [CrossRef]
13. Ando, Y.; Okada, H.; Takemura, G.; Suzuki, K.; Takada, C.; Tomita, H.; Zaikokuji, R.; Hotta, Y.; Miyazaki, N.; Yano, H.; et al. Brain-specific ultrastrucuture of capillsry endothelial glycocalyx and its possible contribution for blood brain barrier. Sci. Rep. 2018, in press. [CrossRef]
14. Inagawa, R.; Okada, H.; Takemura, G.; Suzuki, K.; Takada, C.; Yano, H.; Ando, Y.; Usui, T.; Hotta, Y.; Miyazaki, N.; et al. Ultrastructural Alteration of Pulmonary Capillary Endothelial Glycocalyx During Endotoxemia. Chest 2018, 154, 317–325. [CrossRef]
15. MacAdam, A. The effect of gastro-intestinal mucus on drug absorption. Adv. Drug Deliv. Rev. 1993, 11, 201–220. [CrossRef]
16. Ramaker, K.; Bade, S.; Rockendorf, N.; Meckelein, B.; Vollmer, E.; Schultz, H.; Froschle, G.W.; Frey, A. Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer. PLoS ONE 2016, 11, e0168801. [CrossRef]
17. Hagerbaumer, P.; Vieth, M.; Anders, M.; Schumacher, U. Lectin Histochemistry Shows WGA, PHA-L and HPA Binding Increases During Progression of Human Colorectal Cancer. Anticancer Res. 2015, 35, 5333–5339.
18. Benias, P.C.; Wells, R.G.; Sackey-Aboagye, B.; Klavan, H.; Reidy, J.; Buonocore, D.; Miranda, M.; Kornacki, S.; Wayne, M.; Carr-Locke, D.L.; et al. Structure and Distribution of an Unrecognized Interstitium in Human Tissues. Sci. Rep. 2018, 8, 4947. [CrossRef]
19. Rastogi, V.; Puri, N.; Arora, S.; Kaur, G.; Yadav, L.; Sharma, R. Artefacts: A diagnostic dilemma—A review. J. Clin. Diagn. Res. 2013, 7, 2408–2413. [CrossRef]
20. Potter, R.F.; Groom, A.C. Capillary diameter and geometry in cardiac and skeletal muscle studied by means of corrosion casts. Microvasc. Res. 1983, 25, 68–84. [CrossRef]
21. Chevalier, L.; Selim, J.; Genty, D.; Baste, J.M.; Piton, N.; Boukhalfa, I.; Hamzaoui, M.; Pareige, P.; Richard, V. Electron microscopy approach for the visualization of the epithelial and endothelial glycocalyx. Morphologie 2017, 101, 55–63. [CrossRef]
22. McDonald, D.M.; Baluk, P. Significance of blood vessel leakiness in cancer. Cancer Res. 2002, 62, 5381–5385.
23. Wisse, E.; Braet, F.; Duimel, H.; Vreuls, C.; Koek, G.; Damink, S.W.O.; van den Broek, M.A.; De Geest, B.; Dejong, C.H.; Tateno, C.; et al. Fixation methods for electron microscopy of human and other liver. World J. Gastroenterol. 2010, 16, 2851–2866. [CrossRef]
24. Miettinen, M.; Holthofer, H.; Lehto, V.P.; Miettinen, A.; Virtanen, I. Ulex europaeus I lectin as a marker for tumors derived from endothelial cells. Am. J. Clin. Pathol. 1983, 79, 32–36. [CrossRef]
25. Hollingsworth, M.A.; Swanson, B.J. Mucins in cancer: Protection and control of the cell surface. Nat. Rev. Cancer 2004, 4, 45–60. [CrossRef]
26. Bendris, N.; Stearns, C.J.; Reis, C.R.; Rodriguez-Canales, J.; Liu, H.; Witkiewicz, A.W.; Schmid, S.L. Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells. J. Cell Sci. 2016, 129, 2804–2816. [CrossRef]
27. Bendris, N.; Williams, K.C.; Reis, C.R.; Welf, E.S.; Chen, P.H.; Lemmers, B.; Hahne, M.; Leong, H.S.; Schmid, S.L. SNX9 promotes metastasis by enhancing cancer cell invasion via differential regulation of RhoGTPases. Mol. Biol. Cell 2016, 27, 1409–1419. [CrossRef]
28. Tanigawa, K.; Maekawa, M.; Kiyoi, T.; Nakayama, J.; Kitazawa, R.; Kitazawa, S.; Semba, K.; Taguchi, T.; Akita, S.; Yoshida, M.; et al. SNX9 determines the surface levels of integrin beta1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9. J. Cell. Physiol. 2019, 234, 17280–17294. [CrossRef]
29. Moser, A.R.; Luongo, C.; Gould, K.A.; McNeley, M.K.; Shoemaker, A.R.; Dove, W.F. ApcMin: A mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 1995, 31, 1061–1064. [CrossRef]
30. Wagner, M.; Wiig, H. Tumor Interstitial Fluid Formation, Characterization, and Clinical Implications. Front. Oncol. 2015, 5, 115. [CrossRef]